News

Exciting Conference Participation by Skye Bioscience Ahead

Exciting Conference Participation by Skye Bioscience Ahead

Skye Bioscience's Commitment to Healthcare Innovation

Skye Bioscience, Inc. (NASDAQ: SKYE), a pioneering force in the field of biotechnology, is dedicated to exploring new therapeutic pathways targeting obesity and metabolic health disorders. The company is excited to announce its active participation in several upcoming investment and medical conferences that align with its mission of improving patient outcomes through innovative science.

Upcoming Investment Conferences

Cantor Global Healthcare Conference

The first event is the Cantor Global Healthcare Conference where Skye will be hosting a fireside chat. This interactive session is scheduled for September 5 at 8:00 AM ET, combining insightful discussions with one-on-one meetings. Attendees will gain valuable insights into Skye's strategies and future directions.

H.C. Wainwright Global Investment Conference

Following that, on September 8, Skye will present at the H.C. Wainwright Global Investment Conference at 3:30 PM ET. This presentation offers a platform for Skye to showcase its significant advancements in treatment solutions aimed at metabolic conditions, aiming to attract potential investors interested in the biotechnology sector.

Morgan Stanley Global Healthcare Conference

On September 10, Skye will also participate in the Morgan Stanley Global Healthcare Conference with another engaging fireside chat scheduled for 7:00 AM ET. This event will further emphasize the innovative efforts of Skye within the healthcare market and its commitment to advancing therapeutic solutions.

Engagement in Medical and Scientific Conferences

Obesity Science & Innovation Conference

In addition to investment conferences, Skye is proud to contribute to the Obesity Science & Innovation Conference occurring on September 16 at 9:10 AM ET. Here, the company will partake in a keynote panel discussion titled 'Pipeline priorities - exploring leading and emerging targets shaping the future of obesity therapeutics'. This highlights Skye’s commitment to addressing the challenges of obesity through groundbreaking research.

European Association for the Study of Diabetes Annual Meeting

Moreover, Skye will also be presenting at the European Association for the Study of Diabetes (EASD) Annual Meeting on September 19 at 10:15 AM CET. This oral presentation will cover a critical multi-dose study evaluating the safety and tolerability of nimacimab, an innovative antibody aimed at treating metabolic-associated fatty liver disease (MAFLD).

What Makes Skye Unique?

Skye Bioscience is revolutionizing therapy development by focusing on next-generation molecules that modulate G-protein coupled receptors. The company aims to provide improved therapeutic options backed by substantial human proof of mechanism, creating first-in-class treatments tailored to meet patients' needs effectively. The Phase 2a clinical trial they are conducting evaluates the safety and effectiveness of nimacimab in conjunction with a GLP-1R agonist, further solidifying Skye’s position as a leader in metabolic health.

Stay Updated

Interested parties can access live webcasts and detailed information via Skye's official website. As the field of biotechnology evolves, Skye remains dedicated to transparency and communication with its stakeholders, ensuring they stay informed about crucial developments and upcoming initiatives.

CONTACTS

Investor Relations
ir@skyebioscience.com
(858) 410-0266

Media Inquiries
LifeSci Communications, Michael Fitzhugh
mfitzhugh@lifescicomms.com
(628) 234-3889

Frequently Asked Questions

What areas does Skye Bioscience focus on?

Skye Bioscience primarily focuses on therapeutic pathways for obesity and metabolic health disorders through innovative biotechnology solutions.

When is Skye participating in the upcoming conferences?

Skye will participate in various conferences in September, including investment and medical events dedicated to obesity and diabetes.

What is nimacimab?

Nimacimab is a negative allosteric modulating antibody that Skye is currently testing to evaluate its efficacy and safety in treating various metabolic conditions.

How can I get updates from Skye Bioscience?

Updates can be found on Skye's official website where webcasts and other communications are posted.

Where can I find more information about Skye’s clinical trials?

More information regarding Skye’s clinical trials, including the Phase 2a trial for nimacimab, can be found through clinical trial registries or Skye's website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Potatoes vs. Candy: Halloween's Spuddy Surprise

Updated Category News Views 102

When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...

Continue Reading
2026 Rawlings Gold Glove Award Winners Announced

Updated Category News Views 92

Fielding Excellence on Display: The 2026 Rawlings Gold Glove Awards The Rawlings Gold Glove Awards have once again shone the spotlight on baseball's defensive maestros. Announced by Rawlings Sporting Goods Company, Inc., on November 1, 2026, this year's winners include 11 seasoned veterans and nine greenhorns who claimed their first-ever Gold Gloves. Unveiled during a...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 219

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
Nanchang Expo Showcases Future of Aviation and Space

Updated Category News Views 120

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

Continue Reading
Veteran Surge in 2026 Midterm Elections: A New Wave

Updated Category News Views 19

A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 126

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 287

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
Navigating Underinsured Motorist Coverage Woes

Updated Category News Views 204

When the Rubber Hits the Road: Coverage Gaps Ever been in a fender bender and found out the other driver’s insurance barely covers a dent, let alone a serious crash? Believe me, it's no picnic. Chuck Clark from HelloNation digs into this with a deep dive on underinsured motorist coverage, or UIM for short. It's an eye-opener—especially if you're assuming your auto...

Continue Reading
One Stop Swap eyes school fundraising for growth

Updated Category News Views 69

Transforming Fundraising with a Marketplace Twist Sometimes the real treasures are not tucked in textbooks but found in cluttered closets and basements. Enter One Stop Swap with a big idea—they're cooking up a fundraising strategy for schools that could shake things up by helping families sell their unused stuff. It's got that grassroots vibe with the potential to carve...

Continue Reading
UPM-Kymmene Finalizes Demerger: WISA Group to Nasdaq

Updated Category News Views 141

UPM-Kymmene Shakes Things Up Here's the meat and potatoes: UPM-Kymmene Corporation is going through a big change. They've decided to cut a part of themselves off and send it out into the world. This partial demerger has been registered, and now WISA Group Plc is stepping out from UPM's shadow. Where to? They're headed for the big league, getting listed on Nasdaq Helsinki....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Mexico's Automotive Landscape: A New Milestone

Updated Category News Views 421

Mexico's Automotive Boom: 35.1 Million Vehicles in Operation Recently, it has come to light that there are a staggering 35.1 million vehicles now on the roads of Mexico. This impressive statistic reflects not just the growth in vehicle sales but also the increasing demand for lasting automotive products and services. The data offers a clear look into the changing...

Continue Reading
Mohegan Reports Strong 2024 Results Amidst Growth Strategies

Updated Category News Views 293

Overview of 2024 Financial Performance Mohegan Tribal Gaming Authority has recently released its financial results for the fourth quarter and full fiscal year of 2024. The report indicates a period of remarkable growth and expansion, with significant revenue increases fueled by the successful performance of Mohegan INSPIRE and greater contributions from Mohegan Digital....

Continue Reading
Islamic Center of Detroit Launches Mobile Meals and Distribution

Updated Category News Views 404

New Distribution Center to Combat Food Insecurity The Islamic Center of Detroit (ICD), in partnership with Islamic Relief USA, has proudly opened its first distribution center dedicated to alleviating food insecurity in the community. Situated within the ICD facility, this center will serve as a critical hub, offering essential food supplies and preparing food boxes for...

Continue Reading
Exciting New Fantasy Miniseries Now Streaming on FlexTV

Updated Category News Views 212

FlexTV Premieres Modern Fantasy Miniseries Mega Matrix Inc. (NYSE American: MPU) has exciting news for fans of thrilling narratives! FlexTV, the company’s renowned streaming platform for short dramas, has launched its new modern fantasy miniseries Alpha, She Wasn't the One. This whimsical series skillfully intertwines elements of werewolf lore with a story enriched by...

Continue Reading
DarioHealth Revolutionizes Care with New Health Plan Agreement

Updated Category News Views 105

DarioHealth Expands Reach Through New Health Plan Agreement DarioHealth Corp. (NASDAQ: DRIO) has made a significant move by entering into a new agreement with a large regional health plan, which is part of one of the top 10 health networks in the nation. This partnership marks a significant step forward, enhancing its digital health offerings and positioning itself in a...

Continue Reading